07/10/2025
At DSI, we often hear one critical question from clients bringing new therapies to market: “Do I need a BLA or an NDA?”
While both are formal FDA submission pathways, they apply to very different product types and the regulatory expectations for each are just as unique.
In our latest blog, we simplify the comparison:
✅ When to file a BLA vs. an NDA
✅ Key differences in oversight, data requirements, and manufacturing
✅ How hybrid products like ADCs are reviewed
✅ Tips to align your regulatory strategy early
https://bit.ly/4lQH5Fj
If your team is preparing for an IND, NDA, or BLA, this is a must-read.